Pfizer's stock rose 8.03%, despite bearish technicals and mixed analyst ratings. Technical indicators signal a bearish ...

Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. The FLOTILLA Study, officially titled ‘ENCORAFENIB/BINIMETINIB MASTER ...

Today’s Stock of the Day list features three high-potential picks: Shilpa Medicare, Pfizer, and Vishal Mega Mart. Shilpa ...

Pfizer (PFE) recently announced positive topline results from the Phase 3 EV-303 clinical trial, showcasing promising ...

Pfizer ( PFE 0.22%) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many income investors, questions about the sustainability of the dividend persist.

Pfizer Inc. has just upgraded its 2025 earnings forecast, fueling a bullish sentiment among analysts. After its Q2 earnings ...

Pfizer (PFE) recently announced positive results from its Phase 3 EV-303 clinical trial in collaboration with Astellas Pharma ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...